ES444045A1 - Procedimiento para la obtencion de derivados del acido pros-tanoico. - Google Patents
Procedimiento para la obtencion de derivados del acido pros-tanoico.Info
- Publication number
- ES444045A1 ES444045A1 ES444045A ES444045A ES444045A1 ES 444045 A1 ES444045 A1 ES 444045A1 ES 444045 A ES444045 A ES 444045A ES 444045 A ES444045 A ES 444045A ES 444045 A1 ES444045 A1 ES 444045A1
- Authority
- ES
- Spain
- Prior art keywords
- acid derivatives
- prostanoic acid
- alpha
- prostanoic
- tetranor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- WGJJROVFWIXTPA-OALUTQOASA-N prostanoic acid Chemical class CCCCCCCC[C@H]1CCC[C@@H]1CCCCCCC(O)=O WGJJROVFWIXTPA-OALUTQOASA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003529 luteolytic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4465272A GB1428137A (en) | 1972-09-27 | 1972-09-27 | Prostanoic acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES444045A1 true ES444045A1 (es) | 1977-04-16 |
Family
ID=10434217
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES419143A Expired ES419143A1 (es) | 1972-09-27 | 1973-09-27 | Procedimiento para la obtencion de derivados del acido prostanoico. |
| ES444045A Expired ES444045A1 (es) | 1972-09-27 | 1976-01-02 | Procedimiento para la obtencion de derivados del acido pros-tanoico. |
| ES444047A Expired ES444047A1 (es) | 1972-09-27 | 1976-01-02 | Procedimiento para la obtencion de derivados del acido pros-tanoico. |
| ES444046A Expired ES444046A1 (es) | 1972-09-27 | 1976-01-02 | Procedimiento para la obtencion de derivados del acido pros-tanoico. |
| ES444044A Expired ES444044A1 (es) | 1972-09-27 | 1976-01-02 | Procedimiento para la obtencion de derivados del acido pros-tanoico. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES419143A Expired ES419143A1 (es) | 1972-09-27 | 1973-09-27 | Procedimiento para la obtencion de derivados del acido prostanoico. |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES444047A Expired ES444047A1 (es) | 1972-09-27 | 1976-01-02 | Procedimiento para la obtencion de derivados del acido pros-tanoico. |
| ES444046A Expired ES444046A1 (es) | 1972-09-27 | 1976-01-02 | Procedimiento para la obtencion de derivados del acido pros-tanoico. |
| ES444044A Expired ES444044A1 (es) | 1972-09-27 | 1976-01-02 | Procedimiento para la obtencion de derivados del acido pros-tanoico. |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US3931206A (es) |
| JP (1) | JPS49100071A (es) |
| AR (1) | AR207550A1 (es) |
| AT (1) | AT340610B (es) |
| BE (1) | BE805358A (es) |
| CA (1) | CA1037033A (es) |
| CH (3) | CH597175A5 (es) |
| CS (3) | CS178895B2 (es) |
| DD (1) | DD107899A5 (es) |
| DE (1) | DE2348632A1 (es) |
| EG (1) | EG11278A (es) |
| ES (5) | ES419143A1 (es) |
| FR (1) | FR2200014B1 (es) |
| GB (1) | GB1428137A (es) |
| HU (1) | HU171777B (es) |
| IE (1) | IE38241B1 (es) |
| IL (1) | IL43248A (es) |
| NL (1) | NL7313322A (es) |
| NO (1) | NO145380C (es) |
| PL (2) | PL97363B1 (es) |
| SE (3) | SE424859B (es) |
| SU (1) | SU648088A3 (es) |
| YU (2) | YU254573A (es) |
| ZA (1) | ZA737357B (es) |
| ZM (1) | ZM15873A1 (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1431561A (en) * | 1973-01-31 | 1976-04-07 | Ici Ltd | Cyclopentane derivatives |
| US3953502A (en) | 1973-01-31 | 1976-04-27 | Imperial Chemical Industries Limited | Cyclopentane derivatives |
| GB1507211A (en) * | 1975-02-14 | 1978-04-12 | Ono Pharmaceutical Co | Prostaglandin analogues |
| DE2524955C3 (de) | 1975-06-05 | 1981-12-03 | Hoechst Ag, 6000 Frankfurt | Neue Thienyl-Prostaglandine und Verfahren zu ihrer Herstellung |
| US4464532A (en) * | 1979-07-31 | 1984-08-07 | Nippon Kayaku Kabushiki Kaisha | Intermediates of 7-alkoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1-phthalazone |
| US5545665A (en) * | 1993-12-28 | 1996-08-13 | Allergan | Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
| AU6691798A (en) * | 1997-03-07 | 1998-09-22 | Metabasis Therapeutics, Inc. | Novel indole and azaindole inhibitors of fructose-1,6-bisphosphatase |
| US6284748B1 (en) * | 1997-03-07 | 2001-09-04 | Metabasis Therapeutics, Inc. | Purine inhibitors of fructose 1,6-bisphosphatase |
| JP2001515482A (ja) * | 1997-03-07 | 2001-09-18 | メタバシス・セラピューティクス・インコーポレイテッド | フルクトース−１，６−ビスホスファターゼの新規なベンズイミダゾールインヒビター |
| WO2000014095A1 (en) * | 1998-09-09 | 2000-03-16 | Metabasis Therapeutics, Inc. | Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
| NZ513825A (en) * | 1999-03-05 | 2001-09-28 | Procter & Gamble | C 16 unsaturated FP-selective prostaglandins analogs |
| US6965033B2 (en) * | 1999-12-22 | 2005-11-15 | Metabasis Therapeutics, Inc. | Bisamidate phosphonate prodrugs |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| US7563774B2 (en) * | 2000-06-29 | 2009-07-21 | Metabasis Therapeutics, Inc. | Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes |
| US20090148527A1 (en) * | 2007-12-07 | 2009-06-11 | Robinson Michael R | Intraocular formulation |
| CN101005847A (zh) * | 2004-08-18 | 2007-07-25 | 症变治疗公司 | 果糖1,6－双磷酸酶的新颖噻唑类抑制剂 |
| CN113912539B (zh) * | 2021-12-13 | 2022-03-11 | 山东国邦药业有限公司 | 一种环丙羧酸的合成方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3836578A (en) * | 1965-12-16 | 1974-09-17 | Kemiska Inst | Prostanoic acid derivatives |
| US3726909A (en) * | 1970-10-16 | 1973-04-10 | P Beal | 9,15-dihydroxy prostanoic acids and esters thereof |
-
1972
- 1972-09-27 GB GB4465272A patent/GB1428137A/en not_active Expired
-
1973
- 1973-01-01 AR AR250278A patent/AR207550A1/es active
- 1973-09-12 IE IE1623/73A patent/IE38241B1/xx unknown
- 1973-09-14 US US05/397,327 patent/US3931206A/en not_active Expired - Lifetime
- 1973-09-17 ZA ZA737357*A patent/ZA737357B/xx unknown
- 1973-09-18 IL IL43248A patent/IL43248A/en unknown
- 1973-09-25 HU HU73IE00000590A patent/HU171777B/hu unknown
- 1973-09-25 CA CA181,903A patent/CA1037033A/en not_active Expired
- 1973-09-26 YU YU02545/73A patent/YU254573A/xx unknown
- 1973-09-26 NO NO3779/73A patent/NO145380C/no unknown
- 1973-09-26 SE SE7313112A patent/SE424859B/xx unknown
- 1973-09-26 BE BE136083A patent/BE805358A/xx not_active IP Right Cessation
- 1973-09-26 EG EG374/73A patent/EG11278A/xx active
- 1973-09-26 SU SU731967274A patent/SU648088A3/ru active
- 1973-09-26 FR FR7334504A patent/FR2200014B1/fr not_active Expired
- 1973-09-27 DD DD173723A patent/DD107899A5/xx unknown
- 1973-09-27 CS CS7500003524A patent/CS178895B2/cs unknown
- 1973-09-27 ES ES419143A patent/ES419143A1/es not_active Expired
- 1973-09-27 PL PL1973165466A patent/PL97363B1/pl unknown
- 1973-09-27 DE DE19732348632 patent/DE2348632A1/de not_active Withdrawn
- 1973-09-27 CS CS7300006649A patent/CS178893B2/cs unknown
- 1973-09-27 CH CH1386573A patent/CH597175A5/xx not_active IP Right Cessation
- 1973-09-27 CH CH1363276A patent/CH595341A5/xx not_active IP Right Cessation
- 1973-09-27 NL NL7313322A patent/NL7313322A/xx not_active Application Discontinuation
- 1973-09-27 JP JP48108876A patent/JPS49100071A/ja active Pending
- 1973-09-27 CH CH1363176A patent/CH596164A5/xx not_active IP Right Cessation
- 1973-09-27 CS CS7500003523A patent/CS178894B2/cs unknown
- 1973-09-27 AT AT832673A patent/AT340610B/de not_active IP Right Cessation
- 1973-09-27 ZM ZM158/73A patent/ZM15873A1/xx unknown
- 1973-09-27 PL PL1973185293A patent/PL96782B1/pl unknown
-
1976
- 1976-01-02 ES ES444045A patent/ES444045A1/es not_active Expired
- 1976-01-02 ES ES444047A patent/ES444047A1/es not_active Expired
- 1976-01-02 ES ES444046A patent/ES444046A1/es not_active Expired
- 1976-01-02 ES ES444044A patent/ES444044A1/es not_active Expired
- 1976-10-12 SE SE7611315A patent/SE7611315L/xx unknown
- 1976-10-12 SE SE7611316A patent/SE7611316L/xx unknown
-
1980
- 1980-10-20 YU YU02685/80A patent/YU268580A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES419143A1 (es) | Procedimiento para la obtencion de derivados del acido prostanoico. | |
| ZA744509B (en) | Prostanoic acid derivatives | |
| CA1026329A (en) | Prostaglandin analogues | |
| SE7612262L (sv) | Ketofosfonat-mellanprodukter och forfarande for framstellning derav | |
| ES455104A1 (es) | Un procedimiento para la preparacion de d-homoesteroides. | |
| ES418924A1 (es) | Procedimiento para la obtencion de 13, 14-dihidroprosta- glandinas. | |
| AU474893B2 (en) | New prostaglandin type sulphides | |
| NL7504303A (nl) | Prostaglandinepreparaten. | |
| AU473283B2 (en) | 8,12 prostaglandin analogues | |
| ES430950A1 (es) | Un procedimiento para la preparacion de nitro-alfa-piridonasantialergicas. | |
| AU469908B2 (en) | Prostaglandin analogs | |
| DK137436B (da) | Bæremedium for et hjertestyrkende glycosid. | |
| ES418746A1 (es) | Procedimiento de preparacion de diacetona ceto-2 gulonato de calcio. | |
| ZA746665B (en) | 1,5 (6) - disubstituted benzimidazole - 2 - carbamate derivatives having anthelmintic activity | |
| AU485489B2 (en) | 1, 5(6)-DISUBSTITUTED BENZIMIDAZOLE-2 CARBAMATE DERIVATIVES HAVING ANTHELMINTIC activity | |
| AU6500574A (en) | Prostanoic acid derivatives | |
| AU482145B2 (en) | Prostanoic acid derivatives | |
| AU481170B2 (en) | Prostanoic acid derivatives | |
| CA903767A (en) | Prostanoic acid derivatives | |
| AU486809B2 (en) | 5(6)-benzene ring substituted enzimidazole 2-carbamate derivatives having anthelmintic activity | |
| AU479440B2 (en) | Prostaglandin analogues | |
| AU7059974A (en) | 1, 5(6)-DISUBSTITUTED BENZIMIDAZOLE-2 CARBAMATE DERIVATIVES HAVING ANTHELMINTIC activity | |
| AU461122B2 (en) | S-2, 2' methylene-bis-3 (y-amino) 1, 2-propanediol | |
| CA913564A (en) | PHOTOISOMERIZATION OF .alpha.,.alpha.'-DIMETHYLMUCONIC ACID | |
| AU6396873A (en) | Prostanoic acid derivatives |